Antivirals Flashcards

1
Q

Which parts of the viral replication cycle do antivirals target?

A

Reverse transcription (retroviruses only)

Transcription and translation

Release (cell lysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are examples of viral encoded proteins?

A

Nucleic acid polymerases

Proteases

Integrase

CCR5

Terminase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are limiting factors of antiviral therapies?

A

Host immune response is critical to achieve suppression of viral replication.

Adherence to treatment/antiviral drug resistance.

Drug toxicity

Drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which human herpesviruses are classified as alpha-type?

A

HSV1 + HSV2

VZV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the characteristics of alpha-type human herpesviruses?

A

Rapid growth, latency in sensory ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which human herpesviruses are classified as beta-type?

A

CMV

HHV-6

HHV-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the characteristics of beta-type human herpesviruses?

A

Slow growth, restricted host range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which human herpesviruses are classified as gamma-type?

A

EBV

HHV-8 (KSHV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the characteristics of gamma-type human herpesviruses?

A

Oncogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is chickenpox?

A

Caused by primary infection with varicella-zoster virus (VZV).

Majority uncomplicated in healthy children.

Adults at risk of complications including pneumonitis.

Severe disease in the immunocompromised.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is shingles?

A

Reactivation of latent infection (dorsal root ganglia).

Immunocompetent:

  • Dermatomal distribution
  • Complication: Post-herpetic neuralgia

Immunocompromised: Can experience multidermatomal or disseminated infection with severe complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is 1st line treatment for HSV and VZV?

A

Acyclovir

Varicyclovir (prodrug of acyclovir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is second line treatment for HSV and VZV and why is it used?

A

Famciclovir

Used for ACV-resistant strains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the mode of action of acyclovir?

A

Further elongation of the chain is impossible because acyclovir lacks the 3’ hydroxyl group necessary for the insertion of an additional nucleotide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the pharmacological activity of guanosine analogues?

A

Monophosphorylated by viral thymidine kinase (TK) and then further phosphorylation by cellular kinases to ACV-PPP (active form).

Affinity for herpesvirus DNA polymerase is 10- to 30- fold higher than for cellular (host) DNA polymerase for ACV-PPP.

Selective activity means reduced drug toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the efficacy of guanosine analogues against the alpha-type human herpesviruses?

A

Susceptibility: HSV-1 > HSV-2 >> VZV

VZV 10x less sensitive so higher doses required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the management for HSV encephalitis?

A

On clinical suspicion:

Start empiric treatment immediately with iv ACV 10mg/kg tds without waiting for test results.

If confirmed, treat for 14 - 21 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When is treatment indicated for VZV?

A

Chickenpox in adults (risk of complication: pneumonitis)

Zoster in adults >50 (risk of complication: post-herpetic neuralgia)

1o infection or reactivation in the immunocompromised

Neonatal chickenpox

If there is an increased risk of complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is CMV?

A

MAJOR pathogen in the immunocompromised (including solid organ and bone marrow transplant patients) – causes bone marrow suppression, retinitis, pneumonitis, hepatitis, colitis, encephalitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the treatments for CMV?

A

Ganciclovir - IV

Valganciclovir - PO

Foscarnet - IV/Intravitreal

Cidofovir - IV

+ Letermovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which viruses does Ganciclovir have activity against?

A

Activity against CMV

Also activity against HSV, VZV, EBV and HHV6, but seldom used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are specific indications for ganciclovir?

A

CMV disease in immunocompromised (retinitis, pneumonitis), and neonates with congenital CMV.

Given together with IVIG for CMV pneumonitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are side effects of ganciclovir?

A

Less easily tolerated than ACV.

Bone marrow toxicity (leukopenia, thrombocytopenia, anaemia, pancytopenia).

Renal and hepatic toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are contraindications for ganciclovir?

A

Bone marrow suppression (neutropenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is Foscarnet?

A

Non-competitive inhibitor of viral DNA polymerase

Does NOT require activation by phosphorylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What viruses does Foscarnet have activity against?

A

Activity against CMV, and also occasionally used for HSV (eg if ACV-resistance).

Also activity against VZV, EBV and HHV6, but seldom used.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are specific indications for Foscarnet?

A

CMV disease in patients in whom GCV is contraindicated – ie neutropenic patients (eg pre-engraftment post-BMT); GCV-resistant CMV; CMV retinitis (intravitreal implants).

28
Q

What are side effects of Foscarnet?

A

Nephrotoxic: Keep well hydrated and monitor electrolytes

29
Q

What is Cidofovir?

A

Nucleotide (cytidine) analogue.

Competitive inhibitor of viral DNA synthesis.

Does NOT require activation by phosphorylation.

30
Q

What viruses does Cidofovir have activity on?

A

Activity against CMV, and also occasionally used for HSV (eg if ACV-resistance) and for other viruses (eg adenovirus, BK virus).

31
Q

What are specific indications for Cidofovir?

A

Third line Rx of CMV disease in the immunocompromised

32
Q

What are side effects of Cidofovir?

A

Nephrotoxic: Require hydration + probenicid

33
Q

What are some new antivirals in trial?

A

Maribavir

Letermovir

34
Q

What is Maribavir effective against?

A

Effective in vitro against CMV and EBV: Directly inhibits viral kinase (UL97).

Effective in vitro against GCV-resistant CMV strains.

Ongoing clinical trials for pre-emptive treatment in both SCT and solid organ transplant patients.

35
Q

What are the side effects of Maribavir?

A

Relatively well tolerated

Mainly GI side effects

36
Q

What is Letermovir useful against?

A

A CMV DNA terminase inhibitor.

Now licensed in the UK for CMV prophylaxis in CMV IgG+ HSCT recipients.

CMV specific!

37
Q

What are the side effects of Letermovir?

A

Remains active against GCV-resistant strains.

Well tolerated and safe - Mainly GI side effects.

38
Q

What are potential drug-drug interactions with Letermovir?

A

Drug interactions with immunosuppressants (eg cyclosporine, tacrolimus, sirolimus) - need to monitor drug levels of the above.

39
Q

What is Epstein-Barr Virus?

A

Salivary transmission, infection common in childhood, usually minimally symptomatic and self-limiting.

Classical cause of infectious mononucleosis.

Lifelong infection – continuous low grade viral replication in B lymphocytes kept in check by cellular immune system (immunosurveillance).

Associated with lymphoproliferative disease in the immunocompromised.

40
Q

What is Post-Transplant Lymphoproliferative Disease?

A

Associated with EBV infection.

Breakdown of immunosurveillance.

Latently infected B cells – polyclonal expansion.

Predispose to lymphoma.

41
Q

How is Post-Transplant Lymphoproliferative Disease diagnosed?

A

EBV viral load in blood (> 105 c/ml), biopsy

42
Q

What is the management of Post-Transplant Lymphoproliferative Disease?

A

Reduce immunosuppression (regression in < 50%).

Anti-CD20 monoclonal Ab therapy (B cell marker) – rituximab.

43
Q

A 42-year-old lady is admitted with a 2 day history of fever and confusion and presents with new onset seizures. What antiviral medication should she receive as soon as possible?

A. Oral aciclovir

B. IV foscarnet

C. Oral valaciclovir

D. IV ganciclovir

E. IV aciclovir

A

E. IV aciclovir

44
Q

What are examples of neuraminidase inhibitors?

A

Oseltamivir (Tamiflu, oral)

Zanamivir (Relenza, dry powder inhaler)

45
Q

What are specific indications for neuraminidase inhibitors?

A

Indicated for all patients admitted to hospital due to influenza virus-related respiratory disease.

46
Q

What is Baloxavir?

A

New antiviral in pipeline to treat influenza.

Approved for use in Japan and USA.

Inhibitor of endonuclease activity of the RNA polymerase complex required for viral gene transcription.

47
Q

What is respiratory syncytial virus?

A

Commonest cause of severe respiratory tract illness and hospitalisation of infants worldwide (bronchiolitis).

Associated with subsequent wheeze and asthma diagnosis in later life.

Other risk groups: Elderly, chronic lung disease and the immunocompromised.

48
Q

What is Ribavarin?

A

Guanosine analogue

49
Q

How does Ribavarin work?

A

Inhibits viral RNA synthesis (exact mechanism unclear) – broad activity in vitro: effective for Lassa fever and HEV. Used in combination with other drugs for HCV.

50
Q

What are adverse effects of Ribavarin?

A

Anaemia and possible teratogenicity.

51
Q

Where is IVIg derived and what is it used for?

A

Derived from pooled donors.

Often administered as an adjunct to treatment of viral pneumonitis in the immunocompromised.

52
Q

What is Palivizumab?

A

Monoclonal antibody against RSV

53
Q

What are indications for Palivizumab?

A

For the prevention of serious lower respiratory tract disease caused by RSV in infants at high risk: eg born preterm and severe underlying heart or lung disease (such as bronchopulmonary dysplasia), SCID or long term ventilation.

54
Q

What are antivirals which may be effective against SARS-CoV2?

A

Remdesevir: Broad spectrum adenosine nucleotide analogue pro-drug. iv.

Molnupiravir: Broad spectrum. induces viral RNA mutagenesis.

Paxlovid: Protease inhibitor nirmatrelvir (administered together with low dose ritonavir to increase drug t1/2).

55
Q

What are neutralising monoclonal antibodies which can be used against SARS-CoV2?

A

Ronapreve: (Combination casirivimab + imdevimab), 2.4g iv once only.

Sotrovimab: 500mg iv once only.

Strategy to treat patients who have mild to moderate disease, but who are at high risk of severe disease. Administer as early in the disease process as possible!

56
Q

What are immunomodulators which may be used against SARS-CoV2?

A

Steroids (e.g. dexamethasone)

Cytokine Release Syndrome (CRS):

  • Tocilizumab: IL-6 receptor antagonist
  • Sarilumab: IL-6 receptor antagonist
  • Anakinra: IL-1 receptor antagonist
57
Q

The following statements concern the antiviral drugs oseltamivir and zanamivir. Choose the best answer.

A. Oseltamivir directly inhibits the influenza neuraminidase

B. Zanamivir blocks binding of viral haemagglutinin to host cell sialic acid

C. Oseltamivir inhibits influenza virus uncoating

D. Zanamivir is usually given intravenously

E. Zanamivir is usually given by nebuliser

A

E. Zanamivir is usually given by nebuliser

58
Q

What is BK virus?

A

Part of Polyomavirus family (related to JC virus).

Primary BK virus infection in childhood with minimal symptoms, but subsequent lifelong carriage in kidneys and urinary tract.

59
Q

In which groups of patients does BK virus become problematic?

A

Immunocompromised

BMT: Haemorrhagic cystitis; Less commonly nephritis

Renal transplant: BK nephritis and ureteric stenosis

60
Q

What is the treatment of BK haemorrhagic cystitis?

A

Bladder washouts.

Reduce level of immunosuppression if possible.

Cidofovir iv (+ probenicid) if significant morbidity.

Intravesical cidofovir (5mg/kg/wk) an option if nephrotoxicity.

61
Q

What is the treatment of BK nephropathy?

A

Reduce level of immunosuppression if possible

Normal human immunoglobulin (~ IVIG)

62
Q

In which group of patients do adenoviruses become problematic?

A

Paeds transplant recipients

Severe multi-organ involvement

63
Q

What is the treatment for adenovirus?

A

Cidofovir IV

IVIG

64
Q

What is Brincidofovir?

A

Lipid-conjugated oral prodrug of cidofovir.

Main potential is for treatment of adenovirus and of BK virus disease in the immunocompromised.

65
Q

What are the side effects of Brincidofovir?

A

Less toxicity – mainly diarrhoea and mild transaminitis.

Not licensed in UK.

66
Q

How does CMV become resistant to Ganciclovir?

A

In protein kinase gene (UL97) - most common

In the DNA polymerase gene (UL54) – rare

UL56 terminase gene (letermovir)

67
Q

How does HSV become resistant to ACV?

A

Mutations usually in viral thymidine kinase (95%), and rarely in the viral DNA polymerase (5%).